description1
Product Description
Tirzepatide GMP DMF grade is a high-purity peptide produced under stringent pharmaceutical manufacturing standards. It functions as a dual GIP and GLP-1 receptor agonist, offering enhanced metabolic benefits compared to single receptor agonists. The product exhibits excellent stability, batch consistency, and regulatory compliance, making it an optimal active pharmaceutical ingredient for advanced metabolic disease treatments.
Attributes
| English Name | Tirzepatide | Density | < N/A (lyophilized powder) |
| CAS NO | 1414664-00-3 | Stability | Stable in lyophilized state (sealed, -20℃ to -80℃); avoid repeated freeze-thaw cycles, strong oxidants, and extreme pH conditions |
| Molecular Formula | C₂₂₁H₃₄₈N₆₂O₇₀S₆ | Storage Condition | Sealed, light-proof, and moisture-proof; store at -20℃ to -80℃ in GMP-compliant facilities |
| Mol.wt. | 5123.6 | Solubility | Soluble in water (≥15 mg/mL at 25℃), slightly soluble in methanol |
| EINECS No. | N/A | Form | Powder |
| MDL No. | MFCD34192689 | Colour | White to offwhite lyophilized powder |
| Melting Point | Decomposes above 210℃ (lyophilized form) | pH Value | 4.0-6.0 (0.1% aqueous solution) |
Superior Glycemic Control
Provides enhanced glucose-lowering effects through dual GIP and GLP-1 receptor agonism, achieving greater HbA1c reduction than single GLP-1 receptor agonists.
Significant Weight Reduction
Demonstrates substantial and dose-dependent body weight loss, outperforming existing GLP-1 therapies in clinical studies.
Cardiometabolic Benefits
Improves multiple cardiometabolic parameters including blood pressure, lipid profiles, and hepatic fat content, offering comprehensive metabolic protection.
01
Diabetes Therapeutics
Primary API for injectable formulations targeting type 2 diabetes treatment, particularly for patients requiring enhanced glycemic control and weight management.
01
Obesity Management
Core component in pharmaceutical products developed for chronic weight management in patients with or without type 2 diabetes.
03
Metabolic Syndrome Treatment
Key ingredient in combination therapies addressing multiple aspects of metabolic syndrome, including insulin resistance and associated complications.
0102030405060708

About Us
Shaanxi Bieyouth Biotech Co., Ltd. is proud to offer Tirzepatide, a cutting-edge supplement for those seeking to enhance their cellular health and protect against the ravages of time. By incorporating our Tirzepatide into your health regimen, you are taking a proactive step towards safeguarding your body's cells and promoting a longer, healthier life. Experience the power of this elite antioxidant and embrace the benefits of Tirzepatide for your well-being.






Whatsapp
WeChat
